脂蛋白（a）与主动脉瓣狭窄的加速进展：普遍检测及治疗靶点的理论依据 - Suppr

Suppr

超能文献

Lp(a) and Accelerated Progression of Aortic Stenosis: A Rationale for Universal Measurement and Therapeutic Targeting.

作者信息

Tsimikas Sotirios

机构信息

University of California-San Diego, La Jolla, California, USA.

出版信息

JACC Asia. 2024 Sep 17;4(10):761-763. doi: 10.1016/j.jacasi.2024.08.008. eCollection 2024 Oct.

DOI:10.1016/j.jacasi.2024.08.008

PMID:39553910

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11561483/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8c2a/11561483/af8066f5397c/ga1.jpg

相似文献

Lp(a) and Accelerated Progression of Aortic Stenosis: A Rationale for Universal Measurement and Therapeutic Targeting.脂蛋白（a）与主动脉瓣狭窄的加速进展：普遍检测及治疗靶点的理论依据

JACC Asia. 2024 Sep 17;4(10):761-763. doi: 10.1016/j.jacasi.2024.08.008. eCollection 2024 Oct.

Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis.氧化磷脂、脂蛋白(a)与钙化性主动脉瓣狭窄的进展。

J Am Coll Cardiol. 2015 Sep 15;66(11):1236-1246. doi: 10.1016/j.jacc.2015.07.020.

Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis.脂蛋白(a)和氧化磷脂促进主动脉瓣狭窄患者的瓣膜钙化。

J Am Coll Cardiol. 2019 May 7;73(17):2150-2162. doi: 10.1016/j.jacc.2019.01.070.

Plasma lipoprotein(a) concentration as an independent predictor of hemodynamic progression of aortic valve stenosis.血浆脂蛋白(a)浓度作为主动脉瓣狭窄血液动力进程的独立预测因子。

Mol Cell Biochem. 2020 Sep;472(1-2):199-207. doi: 10.1007/s11010-020-03797-5. Epub 2020 Jun 23.

Lipoprotein(a) and calcific aortic valve stenosis: A systematic review.脂蛋白(a)与钙化性主动脉瓣狭窄：系统综述。

Prog Cardiovasc Dis. 2020 Jul-Aug;63(4):496-502. doi: 10.1016/j.pcad.2020.06.002. Epub 2020 Jun 8.

What is the ultimate test that lowering lipoprotein(a) is beneficial for cardiovascular disease and aortic stenosis?降低脂蛋白(a)对心血管疾病和主动脉瓣狭窄有益的最终检验是什么？

Curr Opin Lipidol. 2014 Dec;25(6):423-30. doi: 10.1097/MOL.0000000000000131.

Impact of plasma Lp-PLA2 activity on the progression of aortic stenosis: the PROGRESSA study.血浆 Lp-PLA2 活性对主动脉瓣狭窄进展的影响：PROGRESSA 研究。

JACC Cardiovasc Imaging. 2015 Jan;8(1):26-33. doi: 10.1016/j.jcmg.2014.09.016. Epub 2014 Nov 1.

Potential Causality and Emerging Medical Therapies for Lipoprotein(a) and Its Associated Oxidized Phospholipids in Calcific Aortic Valve Stenosis.脂蛋白(a)及其相关氧化磷脂在钙化性主动脉瓣狭窄中的潜在因果关系和新兴医学治疗方法。

Circ Res. 2019 Feb;124(3):405-415. doi: 10.1161/CIRCRESAHA.118.313864.

Lipoprotein(a) is associated with the onset but not the progression of aortic valve calcification.脂蛋白(a)与主动脉瓣钙化的发生有关，但与进展无关。

Eur Heart J. 2022 Oct 14;43(39):3960-3967. doi: 10.1093/eurheartj/ehac377.

ApoCIII-Lp(a) complexes in conjunction with Lp(a)-OxPL predict rapid progression of aortic stenosis.载脂蛋白 CIII-脂蛋白(a)复合物与脂蛋白(a)-氧化型磷脂联合预测主动脉瓣狭窄的快速进展。

Heart. 2020 May;106(10):738-745. doi: 10.1136/heartjnl-2019-315840. Epub 2020 Feb 13.

引用本文的文献

2024: The year in cardiovascular disease - the year of lipoprotein(a). Research advances and new findings.2024年：心血管疾病之年——脂蛋白(a)之年。研究进展与新发现。

Arch Med Sci. 2025 Feb 22;21(2):355-373. doi: 10.5114/aoms/202213. eCollection 2025.

本文引用的文献

Lipoprotein(a) and Calcific Aortic Valve Stenosis Progression: A Systematic Review and Meta-Analysis.脂蛋白(a)与钙化性主动脉瓣狭窄进展：系统评价和荟萃分析。

JAMA Cardiol. 2024 Sep 1;9(9):835-842. doi: 10.1001/jamacardio.2024.1882.

Lipoprotein(a) in the Year 2024: A Look Back and a Look Ahead.脂蛋白(a)在 2024 年：回顾与展望。

Arterioscler Thromb Vasc Biol. 2024 Jul;44(7):1485-1490. doi: 10.1161/ATVBAHA.124.319483. Epub 2024 Jun 26.

Lipoprotein(a) levels in a global population with established atherosclerotic cardiovascular disease.脂蛋白(a)水平在已确诊动脉粥样硬化性心血管疾病的全球人群中的水平。

Open Heart. 2022 Oct;9(2). doi: 10.1136/openhrt-2022-002060.

Emerging RNA Therapeutics to Lower Blood Levels of Lp(a): JACC Focus Seminar 2/4.新兴的 RNA 疗法降低脂蛋白(a)的血液水平：JACC 焦点研讨会 2/4。

J Am Coll Cardiol. 2021 Mar 30;77(12):1576-1589. doi: 10.1016/j.jacc.2021.01.051.

Comparison of lipoprotein (a) serum concentrations measured by six commercially available immunoassays.六种市售免疫分析法检测的脂蛋白(a)血清浓度比较。

Atherosclerosis. 2019 Oct;289:206-213. doi: 10.1016/j.atherosclerosis.2019.08.015. Epub 2019 Aug 27.

Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis.脂蛋白(a)和氧化磷脂促进主动脉瓣狭窄患者的瓣膜钙化。

J Am Coll Cardiol. 2019 May 7;73(17):2150-2162. doi: 10.1016/j.jacc.2019.01.070.

Lipoprotein(a) in Patients Undergoing Transcatheter Aortic Valve Replacement.接受经导管主动脉瓣置换术患者的脂蛋白(a)

Angiology. 2019 Apr;70(4):332-336. doi: 10.1177/0003319719826461. Epub 2019 Jan 30.

Association of Mild to Moderate Aortic Valve Stenosis Progression With Higher Lipoprotein(a) and Oxidized Phospholipid Levels: Secondary Analysis of a Randomized Clinical Trial.轻度至中度主动脉瓣狭窄进展与脂蛋白(a)和氧化型磷脂水平升高相关：一项随机临床试验的二次分析。

JAMA Cardiol. 2018 Dec 1;3(12):1212-1217. doi: 10.1001/jamacardio.2018.3798.

NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis.NHLBI 工作组降低脂蛋白(a)介导的心血管疾病和主动脉狭窄风险的建议。

J Am Coll Cardiol. 2018 Jan 16;71(2):177-192. doi: 10.1016/j.jacc.2017.11.014.

Lipoprotein(a) Associated Molecules are Prominent Components in Plasma and Valve Leaflets in Calcific Aortic Valve Stenosis.脂蛋白(a)相关分子是钙化性主动脉瓣狭窄患者血浆和瓣膜小叶中的主要成分。

JACC Basic Transl Sci. 2017 Jun;2(3):229-240. doi: 10.1016/j.jacbts.2017.02.004. Epub 2017 Jun 26.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验